XKRX
226320
Market cap147mUSD
Oct 08, Last price
11,270.00KRW
1D
-4.17%
1Q
9.10%
Jan 2017
-73.79%
IPO
-84.72%
Name
It's Hanbul Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
It'S Hanbul Co., Ltd., a South Korean entity established in 1989 and headquartered in Seoul, focuses on the research, production, and worldwide distribution of cosmetic goods. Operating globally, the company, which was known as It'S SKIN Co., Ltd. until its rebranding in 2017, provides a diverse array of beauty and personal care items. Its comprehensive skincare range includes toners, lotions, serums, gels, creams, emulsions, specialized effectors, eye treatments, sun protection, cleansing solutions, and various masks. For makeup, It'S Hanbul supplies foundational products like BB/CC creams, concealers, illuminators, foundations, and setting powders, in addition to accentuating items such as eye and lip care, eye shadows, brow products, nail care, blushes, and more highlighters. The company also offers body care essentials, including washes, scrubs, lotions, creams, fragrances, and hydrating mists/oils. Furthermore, its portfolio extends to hair care and styling products, dedicated lines for men and babies, hand and foot treatments, and an assortment of beauty accessories, including brushes and applicators.
Key people
Jae Ok Jang
Vice President · since 2021
Jong Hun Son
Assistant Managing Director
Won Gil Yim
Assistant Managing Director
Jin Seong Yim
Chief Executive Officer, Director · since 2024
Chairman · since 2021
Deok Gyun Kim
Non-Executive Independent Director · since 2021
Non-Executive Independent Director
Seong Gyu Lee
Non-Executive Independent Director · since 2018
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||